Literature DB >> 6119712

Initial improvement as predictor of outcome of neuroleptic treatment.

N Nedopil, E Rüther.   

Abstract

Improvement of acute psychotic exacerbations under neuroleptic therapy can depend on the time course of the disease itself, on the individual patient or on the specific neuroleptic applied. Previous studies demonstrated that neither the characteristics of the patients nor the disease qualities could predict the outcome of neuroleptic therapy (review by May and Goldberg 1978). In this study the initial improvement after the onset of neuroleptic treatment was tested for its predictive value. In 33 patients treated with constant doses of butyrophenones the decrease of psychotic symptomatology during the first 5 days of treatment not only accounted for the major part of the overall improvement, but was also a relatively reliable predictor for the further course of the therapy.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6119712     DOI: 10.1055/s-2007-1019599

Source DB:  PubMed          Journal:  Pharmacopsychiatria        ISSN: 0720-4280


  3 in total

1.  Socio-demographic correlates of treatment response among patients with schizophrenia in a tertiary hospital in South-East Nigeria.

Authors:  Mark S Ezeme; Richard Uwakwe; Appolos C Ndukuba; Monday N Igwe; Paul C Odinka; Kennedy Amadi; Nichodemus O Obayi
Journal:  Afr Health Sci       Date:  2016-12       Impact factor: 0.927

2.  The long-term effects of placebo in patients with chronic schizophrenia.

Authors:  R J Wyatt; I D Henter; J J Bartko
Journal:  Biol Psychiatry       Date:  1999-10-15       Impact factor: 13.382

Review 3.  Benperidol for schizophrenia.

Authors:  S Leucht; B Hartung
Journal:  Cochrane Database Syst Rev       Date:  2005-04-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.